Invests in GMP manufacturing
Boston, United States · AUM $3.5B
100focus
BiologicsCell & gene therapyDiagnostics
FDAEMAMHRAPMDA
PORT 246 companies$25M–$100M
Loading…
Venture capital, private equity and strategic investors — matched to your modality, stage and geography.
Scores are deterministic, rules-based — not AI.